@article{ref1,
title="A validation study of the Zanmi Lasante Depression Symptom Inventory (ZLDSI) in a school-based study population of transitional age youth in Haiti",
journal="Conflict and health",
year="2020",
author="Legha, Rupinder K. and Gerbasi, Margaret E. and Smith Fawzi, Mary C. and Eustache, Eddy and Therosmé, Tatiana and Fils-Aimé, J. Reginald and Raviola, Giuseppe J. and Affricot, Emmeline and Pierre, Ermaze Louis and Alcindor, Yoldie and Severe, Jennifer and Boyd, Katherine A. and Grelotti, David J. and Darghouth, Sarah and Rasmussen, Andrew and Becker, Anne E.",
volume="14",
number="",
pages="e13-e13",
abstract="BACKGROUND: The Zanmi Lasante Depression Symptom Inventory (ZLDSI) is a screening tool for major depression used in 12 primary care clinics in Haiti's Central Plateau. Although previously validated in a clinic-based sample, the present study is the first to evaluate the validity and clinical utility of the ZLDSI for depression screening in a school-based population in central Haiti. <br><br>METHODS: We assessed depressive symptoms in a school-based sample of transitional age youth (18-22 years; <i>n</i> = 120) with the ZLDSI. Other mental health-related assessments included a modified Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) for current Major Depressive Episode, the Center for Epidemiologic Studies Depression Scale, and selected items adapted from the Global School-Based Health Survey mental health module. Diagnostic assignments of major depressive episode (MDE) were based on modified SCID interviews. <br><br>RESULTS: The ZLDSI demonstrated good overall accuracy in identifying current MDE (Area under the Curve = .92, 95% CI = .86,.98, <i>p</i> < .001). We ascertained ≥12 as the optimal cut-off point to screen for depression with a sensitivity of 100% and a specificity of 73.9%. In addition, the ZLDSI was associated with other measures of depressive symptoms, suggesting that it demonstrates construct validity. <br><br>CONCLUSIONS: Study findings support that the ZLDSI has clinical utility for screening for depression among school-going transitional age youth.<br><br>© The Author(s). 2020.<p /> <p>Language: en</p>",
language="en",
issn="1752-1505",
doi="10.1186/s13031-020-0250-9",
url="http://dx.doi.org/10.1186/s13031-020-0250-9"
}